首页 | 本学科首页   官方微博 | 高级检索  
     


Omentin as a novel biomarker of metabolic risk factors
Authors:Rei Shibata  Noriyuki Ouchi  Ryotaro Takahashi  Yuya Terakura  Koji Ohashi  Nobuo Ikeda  Akiko Higuchi  Hiroko Terasaki  Shinji Kihara  Toyoaki Murohara
Affiliation:Department of Molecular Cardiology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-Ku, Nagoya, 466-8550, Japan. nouchi@med.nagoya-u.ac.jp.
Abstract:

Background

Omentin is an adipocytokine that is abundantly expressed in visceral fat tissue. We investigated the association of omentin with the number of metabolic risk factors.

Finding

The study population comprised 201 Japanese men who underwent annual health checkups. Plasma omentin levels were determined by enzyme-linked immunosorbent assay. We divided the subjects into 4 groups according to omentin levels. A reduction of plasma omentin levels significantly correlated with an increase in the mean number of metabolic risk factors such as increased waist circumference, dyslipidemia, high blood pressure and glucose intolerance.

Conclusions

Circulating omentin levels negatively correlated with the multiplicity of metabolic risk factors, suggesting that omentin acts as a biomarker of metabolic disorders.
Keywords:
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号